The identity confirmation of 99gTc-DMSA complexes by using NMR and HPLC–MS/MS methods

The analyses of ^99gTc-DMSA complexes prepared under alkali and acidic reactions were reported. Modern analytical, separation and spectral methods such as NMR (¹H-NMR, ¹³C-NMR, APT, COSY and HSQC) and Q-TOF HPLC–MS/MS system with ESI were employed to determine the identity and characterization of the products. The structure of ^99gTc(V)DMSA was clearly confirmed and its fragmentation path in negative and positive ionisation mode was suggested. The effect of ascorbic acid and new alternative labelling with the use of NH ₄ ^99g TcOCl₄ was examined. Surprisingly, ^99gTc(III)DMSA complex was not formed under acidic reaction conditions. ^99gTc(V)DMSA complex was the main reaction product under both experimental conditions. This result suggests the key role of ^99g/99mTc concentration during the process of radiopharmaceuticals preparation.     

The interactions of99mTc phosphorus radiopharmaceuticals and human serum proteins

Dialysis and precipitation methods have been used to study the binding affinity of selected technetium-99m phosphorus radiopharmaceuticals to human serum proteins. The binding affinities of three different^99mTc bone imaging agents were found to be inversely related to their respective clearance rates from blood in vivo. The binding order showed^99mTcPPi>^99mTcHEDP>^99mTcMDP. The^99mTc phosphorus radiopharmaceuticals were bound primarily to alpha globulins. The results suggest that the binding of^99mTc phosphorus radiopharmaceuticals to human serum proteins in blood is largely determined by their affinities to the alpha globulins.     

Effect of experimental conditions on the in vitro stability of99mTc (Sn)-pyrophosphate

The in vitro stability of^99mTc (Sn)-PyP as a function of experimental conditions of the preparation of the kit and time elapsed after labeling has been tested. The preparation was protected by using nitrogen-purged reactant solutions and kit vials and by ascorbic acid. The samples under nitrogen are stable for 6 h when the content of^99mTc-pertechnetate raises to 5%. The best stability was achieved by addition of 5 g of ascorbic acid per ml of the kit (content of^99mTc-pertechnetate about 0.5%). To accelerate the decomposition, exogenous hydrogen peroxide was used. In this case it was found that the presence of 10 g of ascorbic acid inhibits the effect both of oxygen and peroxide (6 g H₂O₂/ml of the kit). Radiochemical purity of^99mTc (Sn)-PyP remains practically unchanged for 6 h (content of^99mTc-pertechnetate about 0.5%).     

In vivo and in vitro 99mTc-protein bound of renal agents: 99mTc-prylidinomethyltetracycline (99mTc-Sn-Pmt) and 99mTc-Sn-Gluco-ene-diolate (99mTc-Gluco)

Protein binding affects tissue distribution, plasma clearance and uptake of renal radiopharmaceuticals. The ^99mTc bound to plasma protein after incubation ^99mTc-Gluco-ene-diolate (^99mTc-Sn-Gluco) agent or ^99mTc-prylidinomethyl-tetracycline (^99mTc-Sn-PMT) agent with plasma protein. It was observed that the protein bound to ^99mTc is lesser extent with (^99mTc-Sn-Gluco) agent than with the ^99mTc-PMT agent. ^99mTc-Sn-PMT is excreted more rapidly than ^99mTc-Sn-Gluco. On the other hand the percentage binding to protein seems to depend on the origin of the protein and or the type of protein (human or animal). However lower human protein binding or higher protein binding were observed with ^99mTc-Sn-Gluco or with ^99mTc-Sn-PMT, respectively compared with the binding to rat protein. The unbroken down of the chemical form of the origin of these two agents and the highest of ^99mTc-Sn-Gluco remained as origin in urine indicate that ^99mTc-Sn-Gluco are more stable than ^99mTc-Sn-PMT.Concerning the type of protein binding to ^99mTc-Sn-PMT or to ^99mTc-Sn-Gluco, it was observed that Human Plasma Protein is greater binding than Human serum protein or than IgG.     

Radiobiokinetic evaluation of domestic cold kits

Domestically produced diagnostic cold kits, viz. glucoheptonate (GH), diisopropyliminodiacetic acid (DISIDA), dimercaptosuccinic acid (DMSA), diethylenetriamine-pentaacetic acid (DTPA), methylenediphosphonate (MDP) and Sn-colloid were labeled with^99mTc and their in-vivo distribution in experimental animals (rats) was evaluated prior to use in humans for diagnostic scanning. The biodistribution pattern was found in accordance with the latest guidelines of the International Atomic Energy Agency (IAEA), which serve as a standard for small scale producers.     

A Freeze Dried Kit for 99mTc(V) Dimercaptosuccinic Acid

^99mTc pentavalent dimercaptosuccinic acid [^99mTc(V) DMSA], a useful agent for imaging thyroid medullary carcinoma and other tumors can be reliably prepared by addition of Na^99mTcO₄ to a freeze-dried mixture of DMSA and Sn (2:1 molar ratio). The radiochemical purity, stability and animal bio-distribution behaviour is similar to that of the agent made by addition of NaHCO₃ to DMSA (III) renal imaging freeze-dried kit.     

Radiolabeling of gemifloxacin with technetium-99m and biological evaluation in artificially <Emphasis Type="Italic">Streptococcus pneumoniae</Emphasis> infected rats

In the current investigation complexation of the gemifloxacin (GIN) with technetium-99 m (^99mTc) and its biological evaluation in artificially Streptococcus pneumoniae (S. pneumoniae) infected rats was assessed as potential S. pneumoniae infection radiotracer. Radiochemically the ^99mTc-GIN complex was further analyzed in terms of stability in saline, in vitro stability in serum at 37 °C, in vitro binding with S. pneumoniae and biodistribution in artificially S. pneumoniae (living and heat killed) infected rats. The complex was found 97.25 ± 0.25% radiochemically stable in saline at 30 min after reconstitution. The stability of the ^99mTc-GIN complex was decreased to 90.50 ± 0.20% within 240 min after reconstitution. In serum the ^99mTc-GIN complex showed stable profile with the appearance of 18.85% free tracer within 16 h of incubation. The ^99mTc-GIN complex showed saturated in vitro binding with S. pneumoniae after different intervals. Almost five fold uptake was observed in living S. pneumoniae infected muscle of the rats as compared to the inflamed and normal muscle. No significant difference in the uptake of heat killed S. pneumoniae infected, inflamed and normal muscles of the rats. The high RCP yield in saline, in vitro permanence in serum, in vitro binding with living S. pneumoniae and biodistribution in artificially S. pneumoniae infected rats we recommend the ^99mTc-GIN as potential S. pneumoniae infection radiotracer.     

99mTc-DMSA complex preparation: the effect of pH and tin(II) chloride amount on reaction

Labelling of meso-2,3-dimercaptosuccinic acid (DMSA) with technetium-99m was reinvestigated. Dependence of the ^99mTc-DMSA complex formation on the molar ratio of DMSA:reducing agent (SnCl₂·2H₂O) and pH was studied. Five different types of ^99mTc-DMSA complexes were determined. Especially three different complexes were established in the clinically used and prepared DMSA kit labelled with ^99mTc under alkaline condition. This radiopharmaceutical is used as imaging agent of the primary medullary carcinoma in the thyroid gland and different metastasis types. The existence of all complexes was observed by paper chromatography, paper electrophoresis and high performance liquid chromatography.     

Rapid and sensitive determination of pertechnetate in99Mo/99mTc generator eluates by reversed-phase high-performance liquid chromatography

Reversed-phase high-performance liquid chromatography with u.v. detection was applied for rapid and sensitive determination of pertechnetate in⁹⁹Mo/^99mTc generator eluates, using a mixture solvent of acetonitrile and 0.04M aqueous acetate buffer (1/1) containing a few volume percentage of 0.5 M tetra-n-butylammonium hydroxide as the mobile phase. Employing a -bondapak C₁₃ column, the TcO ₄ ^– species was separated, monitored with absorbance at 254 nm, and observed at the retention time of 3.5 min. The detection limit was found to be 5.2·10^–10 g of Tc for each injection. Total Tc contents in the^99mTc eluates from clinically-used⁹⁹Mo/^99mTc generator were analyzed by this technique. The^99mTc (⁹⁹Tc) species was separated from the contaminant⁹⁹Mo. This method was found to be useful for the purification of^99mTc (⁹⁹Tc) as well as the determination of total Tc content.     

99mTc-dimercaptosuccinic acid: Analytical procedures for its radiochemical quality control

A procedure for the radiochemical purity control of^99mTc-(2,3-dimercaptosuccinic acid) (DMSA), used as a renal scintigraphic agent is described. The proposed chromatographic system entails the use of two successive solvents, first MEK and second aqueous solution of 5% glycine, on the same supporting medium Gelman ITLC-SG. The procedure is fast and leads to separation and estimation of free pertechnetate, hydrolyzed form of^99mTc and^99mTc — DMSA. This system is superior to the others reported in the literature as the spots of the different species are more distinguished and more concentrated. Its reliability has been studied using dimercaptosuccinic acid kits of different manufacturers and the results have been checked biologically.     

Synthesis and biological evaluation of fatty acid derivatives for myocardial imaging containing [<Superscript>99m</Superscript>Tc(CO)<Subscript>3</Subscript>]<Superscript>+</Superscript>

Radiolabeled fatty acids as myocardial metabolic agent are used for detecting ischemic heart disease, however, no ^99mTc-labeled fatty acids have potential use in clinical diagnosis. In this work, five fatty acid analogues labeled with ^99mTc were firstly synthesized and characterized, their biological behaviors were investigated. All Radiotracers had good stability when incubated in rat serum for 3 h at 37 °C. ^99mTc -CpT-12-ODPPA (8b) showed higher initial myocardial uptake (8.17% ID/g at 1 min postinjection) and good heart/blood ratio (2.58 at 30 min postinjection). ^99mTc-11-dpa-OUFA (2b) as positively charged lipophilic compounds had reasonable heart uptake (5.59% ID/g at 1 min postinjection) and good retention (1.89% ID/g at 60 min postinjection). Unfortunately, no great improvement was obtained by the five ^99mTc-labeled fatty acid analogues for the short myocardial retention and poor heart/liver ratios.     

Comparative study of different gels for quality control of99mTc-radiopharmaceutical kits

The available six types of Sephadex and one type of Sepharose have been applied in the separation of technetium fractions in^99mTc-labelled radiopharmaceuticals produced in our laboratory using the GCS technique. By this technique the chemical state and the percentage of^99mTc-fractions have been determined. The resolution efficiency of some gel types were found to be significantly influenced by the pH of the eluent. The results obtained from the experiments indicated that Sephadex G-25 Fine was the best and can be routinely used in the radiochemical analysis of the following kits:^99mTc-HSA,^99mTc-DTPA and^99mTc-HIDA and G-100 for^99mTc-PYP. With^99mTc-HSA and^99mTc-PYP kits, 0.9% NaCl eluents at pH 3.2 and pH 2 to 2.5, respectively, were found to be necessary for the separation of^99mTc-fractions. G-50 Fine was found to be the best gel between the others in the separation of^99mTc-fractions in testing of the weak radiopharmaceuticals,^99mTc-GH and^99mTc-MDP. The development of^99mTc-MDP with the eluent at the same pH as the preparation gives negligible interaction effect.     

Synthesis and preclinical pharmacological evaluation of a novel 99mTc–shikonin as a potential tumor imaging agent

Shikonin was isolated from Ratanjot pigment then the obtained shikonin was well characterized. This study is aimed to optimize radiolabeling yield of shikonin with ^99mTc with respect to factors that affect the reaction conditions such as shikonin amount, SnCl₂·2H₂O amount, reaction time and pH of the reaction mixture. In vitro stability of the radiolabeled complex was checked and it was found to be stable for up to 6?h. Biodistribution studies showed that, ^99mTc?Cshikonin accumulate in tumor sites with higher T/NT than other currently available ^99mTc(CO)₃-VIP, ^99mTc?Cnitroimidazole analogues and ^99mTc?Cpolyamine analogues indicating that shikonin deliver ^99mTc to the tumor sites with a percentage sufficient for imaging and can overcome many drawbacks of other radiopharmaceuticals used for tumor imaging.     

The quality of99mTc eluates

The possible effects of several protecting procedures on the quality of^99mTc eluates were investigated. The content of⁹⁹Mo in the eluates (⁹⁹Mo breakthrough) was expressed in (%) with respect to the total adsorbed⁹⁹Mo radioactivity and in () i.e. as the ratio of⁹⁹Mo and^99mTc radioactivities in each particular eluate. The radiochemical purity was expressed in (%) of^99mTc(VII) in the eluates. The content of Al³⁺ and Cu²⁺ as chemical impurities was also determined.     

<Superscript>99m</Superscript>TcN–gatifloxacin dithiocarbamate complex: a novel multi-drug-resistance <Emphasis Type="Italic">Streptococcus pneumoniae</Emphasis> (MRSP) infection radiotracer

Gatifloxacin (GTN) was derivatized to its dithiocarbamate derivative and its radiolabeling with technetium-99m (^99mTc) using the [^99mTc≡N]²⁺ core was investigated. The appropriateness of the ^99mTcN–gatifloxacin dithiocarbamate (^99mTcN–GTND) complex as a potential multi-drug-resistance Streptococcus pneumoniae (MRSP) infection radiotracer was evaluated in terms of stability in saline, serum, in vitro binding with MRSP and biodistribution in artificially MRSP infected Male Wistar Rats (MWR). In saline the ^99mTcN–GTND complex showed more than 90% labeling yield up to 4 h with a maximum yield of 98.25 ± 0.20%, after reconstitution. In serum the ^99mTcN–GTND complex showed stability up to 16 h of incubation with the appearance of insignificant 15.95% undesirable side products. The ^99mTcN–GTND complex demonstrated saturated in vitro binding with MRSP with a maximum value of 75.50 ± 1.00% (at 90 min). In MWR model of group A, almost six times higher uptake of the labeled GTND was monitored in the muscle of MWR infected with live MRSP as compared to the inflamed and normal muscles. Based on the higher labeling yield in saline, in vitro stability in serum, saturated in vitro binding with live MRSP and promising biodistribution in MWR model we recommend ^99mTcN–gatifloxacin dithiocarbamate complex as a potential MRSP infection radiotracer.     

Aqueous syntheses of [(Cp-R)M(CO)3] type complexes (Cp = cyclopentadienyl, M = Mn, Tc, Re) with bioactive functionalities

We describe reactions of [^99mTc(H₂O)₃(CO)₃)]⁺ (1) with Diels-Alder products of cyclopentadiene such as “Thiele’s acid” (HCp-COOH)₂ (2) and derivatives thereof in which the corresponding [(Cp-COOH)^99mTc(CO)₃)] (3) complex did form in water. We propose a metal mediated Diels-Alder reaction mechanism. To show that this reaction was not limited to carboxylate groups, we synthesized conjugates of 2 (HCp-CONHR)₂ (4a-c) (4a, R = benzyl amine; 4b, R = N_α-Boc-l-2,3-diaminopropionic acid and 4c, R = glycine). The corresponding ^99mTc complexes [(4a)^99mTc(CO)₃)] 6a, [(4b)^99mTc(CO)₃)] 6b and [(4c)^99mTc(CO)₃)] 6c have been prepared along the same route as for Thiele’s acid in aqueous media demonstrating the general applicability of this synthetic strategy. The authenticity of the ^99mTc complexes on the no carrier added level have been confirmed by chromatographic comparison with the structurally characterized manganese or rhenium complexes.Studies of the reaction of 1 with Thiele’s acid bound to a solid phase resin demonstrated the formation of [(Cp-COOH)^99mTc(CO)₃)] 3 in a heterogeneous reaction. This is the first evidence for the formation of no carrier added ^99mTc radiopharmaceuticals containing cyclopentadienyl ligands via solid phase syntheses. Macroscopically, the manganese analogue 5a and the rhenium complexes 5b-c have been prepared and characterized by IR, NMR, ESI-MS and X-ray crystallography for 5a (monoclinic, P2₁/c, a = 9.8696(2) Å, b = 25.8533(4) Å, c = 11.8414(2) Å, β = 98.7322(17)°) in order to unambiguously assign the authenticity of the corresponding ^99mTc complexes.     

A new detection method of99Tc by nuclear excitation

A new nuclear excitation process,⁹⁹Tc (, )^99mTc reaction, was applied for the first time to radioactivation analysis of technetium. Bremsstrahlung irradiation of⁹⁹Tc samples gave the reaction product^99mTc which emits -ray measurable with ease by a semiconductor detector. The production rate of^99mTc per g⁹⁹Tc was linearly correlated with the flux of bremsstrahlung. The detection limit of⁹⁹Tc was estimated to be nanogram order (0.63 Bq⁹⁹Tc) under the optimum irradiation condition. Possible interference by¹⁰⁰Ru(, p)^99mTc reaction was also studied, which could be discriminated from the (, ) reaction by simultaneously occurring⁹⁸Ru (, p)⁹⁷Ru reaction.     

Chromatographic and biological comparison of99mTc-DMSA prepared by direct labelling and ligand exchange reaction

^99mTc-dimercaptosuccinic acid /DMSA/ is one of the most favourable agents used for renal scintigraphy. This radiopharmaceutical was prepared in two different ways: by direct labelling of tin/II/-dimercaptosuccinic acid and by ligand exchange reaction from^99mTc-gluconate at tracer concentration of technetium under acidic condition. The complexes formed were compared using paper chromatography, thin layer chromatography, gel filtration and electrophoresis. Their biodistribution was studied on rats.